Pfizer and Valneva have shared encouraging results from a late-stage clinical trial of their Lyme disease vaccine, offering new hope in the fight against a growing health concern.
Godavari Biorefineries Limited has secured a Japan patent for antiviral compounds, marking a fresh step in its expanding life sciences research.
Uttar Pradesh pharma investment is gaining strong momentum as the state moves ahead with a INR2,500 crore plan to build a robust healthcare manufacturing ecosystem.
Bristol Myers Squibb has secured a major regulatory win as the FDA approves its cancer drug for stage IV. The drug, Opdivo (nivolumab) is for patients with advanced classical Hodgkin lymphoma, marking a shift in how the disease is treated...
Sun Pharmaceutical Industries Limited has rolled out its semaglutide injection in India under the brands Noveltreat and Sematrinity, widening access to treatments for type 2 diabetes and chronic weight management.
Glenmark Pharmaceuticals has launched its new diabetes drug, Glipiq, in India, with a clear focus on making advanced treatment more affordable and accessible. The move comes as the country continues to see a sharp rise in type 2 diabetes, placin...
The Union Ministry of Health and Family Welfare has stepped up efforts to tackle HIV/AIDS in India by focusing on stronger action at the district level. As part of this initiative, the Suraksha Sankalp Karyashala was recently held in Delhi, brin...
Indian Pharma Companies have kicked off an aggressive race in generic semaglutide after the patent for the blockbuster diabetes and weight-loss drug expired on March 20, 2026.
India’s pharmaceutical and medtech sectors are rapidly transforming into a global force, creating new opportunities for the nation’s economy. Union Minister Dr. Jitendra Singh said today that the country is steadily evolving...
India’s push to lead in gene therapy clinical progress took center stage in Parliament today as officials from the government detailed how the country is advancing cutting edge treatments while relying on a firm regulatory system.